icon
0%

Corteva CTVA - News Analyzed: 6,672 - Today: 100 - Last Week: 100 - Last Month: 500

⇑ Corteva CTVA Dominates BioTech Market with Increased Growth

Corteva CTVA Dominates BioTech Market with Increased Growth
Corteva Inc., an industry-leading agricultural bio-tech company, has been making headlines with numerous positive announcements. They've recently entered into a partnership with FMC to expand the presence of a fungicide in the U.S markets. The companies' stock, symbol CTVA, has been upgraded to positive from dealers and financial institutions such as Jefferies, BWG Global, and Argus Research, all of which cite improved demand and growth potential. Jefferies has also raised Corteva's price target to $92 from $80. CTVA is among the best performing agriculture stocks to buy. There's a lot to admire which include its growing dividends and strategic advantages in the market. Notable forecasts reveal that Corteva is expected to beat earnings estimates. Inside CTVA, the Senior VP sold 27% of their shares and a dividend payout for Q2 2025 has been announced. Other impressive insights reveal Corteva's investment in a desert bacteria startup, a new partnership with bp for aviation fuel production, Price Target upgrades from UBS and Citi, and a share repurchase program.

Corteva CTVA News Analytics from Tue, 17 Sep 2024 07:00:00 GMT to Fri, 06 Jun 2025 19:30:39 GMT - Rating 8 - Innovation 7 - Information 9 - Rumor 9

The email address you have entered is invalid.